Novel 19-nor-hexafluoride vitamin D3 analog (Ro 25-6760) inhibits human colon cancer in vitro via apoptosis

International Journal of Oncology

Volumn 14, Issue 5, 1999, Pages 979-985

  Evans, Stephen R T ^a,c   Soldatenkov, Viatcheslav ^b   Shchepotin, Evgeny B ^a   Bogrash, Elena ^a   Shchepotin, Igor B ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Colon cancer; In vitro; Synthetic analogs; Vitamin D

Indexed keywords

ANTINEOPLASTIC AGENT; CALCITRIOL; CDKN1A PROTEIN, HUMAN; COLECALCIFEROL; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; DRUG DERIVATIVE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PEPTIDE HYDROLASE; RO 25 6760; RO 25-6760;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIVISION; CELL STRAIN HT29; COLON TUMOR; DRUG EFFECT; HUMAN; METABOLISM; PATHOLOGY; UPREGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CALCITRIOL; CELL DIVISION; CHOLECALCIFEROL; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; G0 PHASE; G1 PHASE; HT29 CELLS; HUMANS; PEPTIDE HYDROLASES; POLY(ADP-RIBOSE) POLYMERASES; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0033125538     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.14.5.979     Document Type: Article

References (34)

1. Garland CF and Garland FC: Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 9: 227-231, 1980.
2. Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK and Gorham ED: Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 2: 1176-1178, 1989.
3. Garland C, Shekelle RB, Barrett-Connor E, Criqui MH, Rossof AH and Paul O: Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet 1: 307-309, 1985.
4. Haussler MR and Norman AW: Chromosomal receptor for a vitamin D metabolite. Proc Natl Acad Sci USA 62: 155-162, 1969.
5. Baker AR, McDonnell DP, Hughes M, Crisp TM, Mangelsdorf DJ, Haussler MR, Pike JW, Shine J and O'Malley BW: Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA 85: 3294-3298, 1988.
6. Guiliano AR, Franceschi RT and Wood RJ: Characterization of the vitamin D receptor from the Caco-2 human colon carcinoma cell line: effect of cellular differentiation. Arch Biochem Biophys 285: 261-269, 1991.
7. 3 receptors and human colon adenocarcinoma. Br J Surg 78: 435-439, 1991.
8. Buras RR, Schumaker LM, Davoodi F, Brenner RV, Shabahang M, Nauta RJ and Evans SRT: Vitamin D receptors in breast cancer cells. Breast Cancer Res Treatment 31: 191-202, 1994.
9. 3 on the growth of soft tissue sarcoma cells as mediated by the vitamin D receptor. Ann Surg Oncol 3: 144-149, 1996.
10. 3 in human malignant melanoma cell lines. J Surg Res 61: 127-133, 1996.
11. 3 receptor as a marker of human colon carcinoma cell line differentiation and its effect on growth inhibition. Cancer Res 53: 1-7, 1993.
12. 3. Cancer Res 54: 4057-4064, 1994.
13. 3 and its synthetic analog, 1α,25-dihydroxy-16-ene-23yne-26,27-hexafluoro-19-nor-cholecalciferol (Ro 25-6760), on a human colon cancer xenograft. Clin Cancer Res (In press).
14. Evans SR, Nolla J, Hanfelt J, Shabahang M, Nauta RJ and Shchepotin IB: Vitamin D receptor expression as a predictive marker of biological behavior in human colorectal cancer. Clin Cancer Res 4: 1591-1595, 1998.
15. Shchepotin IB, Soldatenkov V, Shabahang M, Buras RR, Nauta RJ and Evans SRT: The effect of hyperthermia and verapamil on primary and metastatic colon adenocarcinoma cell lines: inhibition of proliferation, cell cycle distribution and onset of apoptosis. Oncol Rep 2: 473-479, 1995.
16. Soldatenkov V, Prasad S, Voloshin Y and Dritschilo A: Sodium butyrate induces apoptosis and accumulation of ubiquitinated proteins in human breast carcinoma cells. Cell Death Differ 5: 307-312, 1998.
17. Bouillon R, Verstuyf A, Verlinden L, Allewaert K, Branisteanu D, Mathieu C and van Baelen H: Non-hypercalcemic pharmacological aspects of vitamin D analogs. Biochem Pharmacol 50: 577-583, 1995.
18. 3 is linked to dephosphorylation of retinoblastoma gene product. Biochem Biophys Res Commun 196: 487-493, 1993.
19. 3: a novel class of potent inhibitors of proliferation of human breast cell lines. Cancer Res 57: 4545-4550, 1997.
20. kip1 and E-cadherin. J Mol Endocrinol 19: 15-27, 1997.
21. 3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells. Breast Cancer Res Treat 42: 31-41, 1997.
22. 3 derivatives on growth, differentiation and apoptosis in tumoral colonic HT-29 cells: possible implication of intracellular calcium. Cancer Lett 97: 99-106, 1995.
23. Welsh JE: Induction of apoptosis in breast cancer cells in response to vitamin D and antiestrogens. Biochem Cell Biol 72: 537-545, 1994.
24. 3 analogs: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cells. Cancer Res 55: 2822-2830, 1995.
25. Van Leeuwen JPTM and Pols HAP: Vitamin D: anticancer and differentiation. In: Vitamin D. Feldman D, Glorieux FH and Pike JW (eds). Academic Press, pp1089-1105, 1997.
26. Barinaga M: Death by dozen of cuts. Science 280: 32-34, 1998.
27. Gjertsen B and Doskeland SO: Protein phosphorylation in apoptosis. Biochem Biophys Acta 1269: 187-199, 1995.
28. Hale AJ, Smith CA, Sutherland LC, Stoneman VE, Longthorne V, Culhane AC and Williams GT: Apoptosis: molecular regulation of cell death. Eur J Biochem 236: 1-26, 1996.
29. Hulla W, Kallay E, Krugluger W, Peterlik M and Cross HS: Growth control of human colon-adenocarcinoma-derived Caco-2 cells by vitamin D compounds and extracellular calcium in vitro: relation to c-Myc oncogene and vitamin D-receptor expresion. Int J Cancer 62: 711-716, 1995.
30. Shehepotin I, Soldatenkov V, Wroblewski J, Surin A, Shabahang M, Buras RR, Nauta R, Pulyaeva H and Evans SRT: Apoptosis induced by hyperthermia and verapamil in vitro in a human colon cancer cell line. Int J Hyperthermia 13: 547-557, 1997.
31. Rodrigues NR, Rowan A, Smith MEF, Kerr J, Bodmer WF, Gannon JV and Lane D: P53 mutations in colorectal cancer. Proc Natl Acad Sci USA 87: 7555-7559, 1990.
32. Shao ZM, Dawson MI, Li XS, Rishi AK, Sheikh MS, Han QX, Ordonez JV, Shroot B and Fontana JA: P53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene 11: 493-504, 1995.
33. Wu G, Fan RS, Li W, Ko TC and Brattain MG: Modulation of cell cycle control by vitamin D, and its analogue, EB1089, in human breast cancer cells. Oncogene 15: 1555-1563, 1997.
34. Kawa S, Nikaido T, Aoki Y, Zhai Y, Kumagai T, Furihata K, Fujii S and Kiyosawa K: Vitamin D analogues up-regulate p21 and p27 during growth inhibition of pancreatic cancer cell lines. Br J Cancer 76: 884-889, 1997.